Misoprostol for Secondary Prevention of Postpartum Hemorrhage at the Community Level in India
NCT01462422 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 3032
Last updated 2014-06-16
Summary
This study compares two community-level strategies: selective administration of 800 mcg sublingual misoprostol to women at 350 mL blood loss for secondary prevention of postpartum hemorrhage (PPH) with universal use of 600 mcg oral misoprostol at the time of delivery for primary prevention of PPH. The study hypothesizes that at community-level births, secondary prevention for women is non-inferior (based on clinical parameters) to universal prophylaxis provided to women for primary prevention of PPH. This cluster-design non-inferiority trial has the potential to inform service delivery programs on clinical outcomes, program feasibility, cost and acceptability of two different community models of PPH care using misoprostol.
Conditions
- Postpartum Hemorrhage
Interventions
- DRUG
-
Selective administration of 800 mcg sublingual misoprostol to women with at least 350 mL blood loss within 1 hour following delivery
- DRUG
-
Universal administration of 600 mcg oral misoprostol given to all women within 5 minutes of delivery of the baby
Sponsors & Collaborators
-
Sri B. M. Patil Medical College, Bijapur, Karnataka, India
collaborator UNKNOWN -
Jawaharlal Nehru Medical College
collaborator OTHER -
University of Illinois at Chicago
collaborator OTHER -
University of California, San Francisco
collaborator OTHER -
Gynuity Health Projects
lead OTHER
Principal Investigators
-
Beverly Winikoff, MD, MPH · Gynuity Health Projects
-
Sheila Raghavan, MSc · Gynuity Health Projects
-
Stacie Gellar, PhD · University of Illinois at Chicago
-
Suellen Miller, PhD, CNM · University of California, San Francisco
-
Shivaprasad S Goudar, MD, MHPE · Jawaharlal Nehru Medical College
Study Design
- Allocation
- RANDOMIZED
- Purpose
- HEALTH_SERVICES_RESEARCH
- Masking
- NONE
- Model
- PARALLEL
Eligibility
- Min Age
- 15 Years
- Max Age
- 45 Years
- Sex
- FEMALE
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2011-12-31
- Primary Completion
- 2014-03-31
- Completion
- 2014-03-31
Countries
- India
Study Locations
More Related Trials
-
A Study of Self-administered Misoprostol to Prevent Bleeding After Childbirth in the Community (MamaMiso)
NCT01510574 ·Status: COMPLETED ·Phase: NA
-
Misoprostol for Treatment of Postpartum Haemorrhage (PPH) in Home Births
NCT01508429 ·Status: COMPLETED ·Phase: NA
-
Misoprostol for the Prevention of Postpartum Hemorrhage in Rural Pakistan
NCT00120237 ·Status: COMPLETED ·Phase: NA
-
Misoprostol and Oxytocin in Uniject® for Postpartum Hemorrhage Prevention in Communities
NCT01710566 ·Status: WITHDRAWN ·Phase: PHASE3
-
Misoprostol as First Aid Measure to Address Excessive Postpartum Bleeding
NCT02853552 ·Status: UNKNOWN ·Phase: PHASE4
-
Comparison of Primary and Secondary Prevention of Postpartum Hemorrhage at the Community Level in Egypt
NCT02226588 ·Status: COMPLETED ·Phase: PHASE4
-
Misoprostol for Treatment of Postpartum Hemorrhage at Community-level Births in Egypt
NCT01619072 ·Status: COMPLETED ·Phase: NA
-
Comparison Between Preoperative Vaginal and Postoperative Sublingual Misoprostol for Prevention of Postpartum Hemorrhage During Cesarean Section
NCT06765473 ·Status: NOT_YET_RECRUITING ·Phase: PHASE3
-
Treatment of Postpartum Haemorrhage (PPH) Using Misoprostol in Home Births
NCT01485562 ·Status: COMPLETED ·Phase: NA
-
Prevention of Postpartum Haemorrhage With Sublingual Misoprostol or Oxytocin
NCT01373359 ·Status: COMPLETED ·Phase: PHASE3
-
Fever After Misoprostol Administration for the Treatment of Primary Postpartum Hemorrhage
NCT01080846 ·Status: COMPLETED ·Phase: NA
-
Treatment of Incomplete Abortion With 600 Mcg Oral Misoprostol Compared to Standard Surgical Treatment
NCT00674232 ·Status: COMPLETED ·Phase: NA
-
Sublingual Misoprostol Versus Standard Surgical Care for the Treatment of Incomplete Abortion
NCT00466999 ·Status: COMPLETED ·Phase: NA
-
The Effect of Rectal and Sublingual Misoprostol Administration in Postpartum or Intrapartum Haemorrhage at Elective Caesarean Delivery: a Randomized Controlled Trial
NCT01931410 ·Status: COMPLETED ·Phase: PHASE4
-
The Efficacy and Safety of Preoperative Misoprostol in Blood-loss Reduction During Myomectomy.
NCT03509168 ·Status: UNKNOWN ·Phase: PHASE2/PHASE3
-
Misoprostol Treatment of Mid Trimester Incomplete Abortion by Midwives and Doctors in Uganda.
NCT03622073 ·Status: COMPLETED ·Phase: NA
-
Pre Versus Post-operative Misoprostol in Reducing Blood Loss After Cesarean Section
NCT05928871 ·Status: UNKNOWN ·Phase: PHASE4
-
Combating Maternal Mortality in Uganda: An Assessment of the Role of Misoprostol in Prevention of Post-Partum Hemorrhage
NCT01866241 ·Status: COMPLETED ·Phase: PHASE3
-
400mcg Sublingual Misoprostol as First Line Treatment
NCT01939457 ·Status: COMPLETED ·Phase: NA
-
Comparative Study on the Effects of Sublingual Misoprostol in Addition to Standard AMTSL in Low Risk Parturients in LASUTH, Ikeja.
NCT02424201 ·Status: UNKNOWN ·Phase: EARLY_PHASE1
-
Comparing Misoprostol and Oxytocin in UnijectTM for Postpartum Hemorrhage (PPH) Prevention in Mali
NCT01487278 ·Status: WITHDRAWN ·Phase: NA
-
Misoprostol for the Treatment of Incomplete Abortion
NCT00670761 ·Status: COMPLETED ·Phase: NA
-
Misoprostol Versus Oxytocin for Prevention of Post Partum Hemorrhage
NCT01863706 ·Status: COMPLETED ·Phase: PHASE1
-
Rectal Misoprostol Versus Sublingual Misoprostol Prior to Myomectomy
NCT02716142 ·Status: COMPLETED ·Phase: PHASE4
-
Intrauterine Misoprostol Versus Intravenous Oxytocin Infusion During Cesarean Delivery
NCT03148574 ·Status: COMPLETED ·Phase: PHASE3